These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 11576197

  • 1. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group.
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [Abstract] [Full Text] [Related]

  • 2. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J, Bussone G, Hernandez JF, Allen C, Vrijens F, Patel K, Rizatriptan-Sumatriptan Preference Study Group.
    Eur Neurol; 2001 Sep; 45(4):275-83. PubMed ID: 11385269
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [Abstract] [Full Text] [Related]

  • 4. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE, Billups SJ, Delate T, Hoffman CK, Carroll N.
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [Abstract] [Full Text] [Related]

  • 5. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S, Frishberg B, Hu XH, Markson L, Berger M.
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [Abstract] [Full Text] [Related]

  • 6. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J, Fité B, López-Gil A.
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [Abstract] [Full Text] [Related]

  • 7. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
    Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, Lines C.
    Headache; 1998 Feb; 38(10):737-47. PubMed ID: 11284462
    [Abstract] [Full Text] [Related]

  • 8. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR.
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [Abstract] [Full Text] [Related]

  • 9. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Tørring J.
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [Abstract] [Full Text] [Related]

  • 10. Real-world experiences in migraine therapy with rizatriptan.
    Jamieson D, Cutrer FM, Goldstein J, Dayno J, Hu XH, USMAP Investigators.
    Headache; 2003 Mar; 43(3):223-30. PubMed ID: 12603640
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
    Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D.
    Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
    [Abstract] [Full Text] [Related]

  • 12. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 13. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Mathew NT, Kailasam J, Gentry P, Chernyshev O.
    Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
    [Abstract] [Full Text] [Related]

  • 14. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M, Faulds D.
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [Abstract] [Full Text] [Related]

  • 15. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ, Charlesworth BR.
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [Abstract] [Full Text] [Related]

  • 16. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ, Evers S, Kinge E, Allais G, Allen C, Rao NA, Massaad R, Lis K.
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [Abstract] [Full Text] [Related]

  • 17. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S, Göbel H, Mateos V, Allen C, Vrijens F, Shivaprakash M, Rizatriptan-Ergotamine/Caffeine Preference Study Group.
    Eur Neurol; 2003 Mar; 49(1):20-9. PubMed ID: 12464714
    [Abstract] [Full Text] [Related]

  • 18. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
    [Abstract] [Full Text] [Related]

  • 19. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 20. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
    Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD.
    Arch Neurol; 1996 Nov; 53(11):1132-7. PubMed ID: 8912486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.